Global Gastroparesis Drugs Market Growth 2022-2028
As the global economy mends, the 2021 growth of Gastroparesis Drugs will have significant change from previous year. According to our latest study, the global Gastroparesis Drugs market size is USD million in 2022 from USD 5535.9 million in 2021, with a change of % between 2021 and 2022. The global Gastroparesis Drugs market size will reach USD 7513.8 million in 2028, growing at a CAGR of 4.5% over the analysis period.
The United States Gastroparesis Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gastroparesis Drugs market, reaching US$ million by the year 2028. As for the Europe Gastroparesis Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gastroparesis Drugs players cover Sumitomo, Cadila Pharmaceuticals, Sanofi, and Teva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastroparesis Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Prokinetic Agents
Antiemetic Agents
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Diabetic Gastroparesis
Idiopathic Gastroparesis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gastroparesis Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Gastroparesis Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Gastroparesis Drugs by Country/Region, 2017, 2022 & 2028
2.2 Gastroparesis Drugs Segment by Type
2.2.1 Prokinetic Agents
2.2.2 Antiemetic Agents
2.2.3 Others
2.3 Gastroparesis Drugs Sales by Type
2.3.1 Global Gastroparesis Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Gastroparesis Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Gastroparesis Drugs Sale Price by Type (2017-2022)
2.4 Gastroparesis Drugs Segment by Application
2.4.1 Diabetic Gastroparesis
2.4.2 Idiopathic Gastroparesis
2.5 Gastroparesis Drugs Sales by Application
2.5.1 Global Gastroparesis Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Gastroparesis Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Gastroparesis Drugs Sale Price by Application (2017-2022)
3 Global Gastroparesis Drugs by Company
3.1 Global Gastroparesis Drugs Breakdown Data by Company
3.1.1 Global Gastroparesis Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Gastroparesis Drugs Sales Market Share by Company (2020-2022)
3.2 Global Gastroparesis Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Gastroparesis Drugs Revenue by Company (2020-2022)
3.2.2 Global Gastroparesis Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Gastroparesis Drugs Sale Price by Company
3.4 Key Manufacturers Gastroparesis Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gastroparesis Drugs Product Location Distribution
3.4.2 Players Gastroparesis Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Gastroparesis Drugs by Geographic Region
4.1 World Historic Gastroparesis Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Gastroparesis Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Gastroparesis Drugs Annual Revenue by Geographic Region
4.2 World Historic Gastroparesis Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Gastroparesis Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Gastroparesis Drugs Annual Revenue by Country/Region
4.3 Americas Gastroparesis Drugs Sales Growth
4.4 APAC Gastroparesis Drugs Sales Growth
4.5 Europe Gastroparesis Drugs Sales Growth
4.6 Middle East & Africa Gastroparesis Drugs Sales Growth
5 Americas
5.1 Americas Gastroparesis Drugs Sales by Country
5.1.1 Americas Gastroparesis Drugs Sales by Country (2017-2022)
5.1.2 Americas Gastroparesis Drugs Revenue by Country (2017-2022)
5.2 Americas Gastroparesis Drugs Sales by Type
5.3 Americas Gastroparesis Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastroparesis Drugs Sales by Region
6.1.1 APAC Gastroparesis Drugs Sales by Region (2017-2022)
6.1.2 APAC Gastroparesis Drugs Revenue by Region (2017-2022)
6.2 APAC Gastroparesis Drugs Sales by Type
6.3 APAC Gastroparesis Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Gastroparesis Drugs by Country
7.1.1 Europe Gastroparesis Drugs Sales by Country (2017-2022)
7.1.2 Europe Gastroparesis Drugs Revenue by Country (2017-2022)
7.2 Europe Gastroparesis Drugs Sales by Type
7.3 Europe Gastroparesis Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gastroparesis Drugs by Country
8.1.1 Middle East & Africa Gastroparesis Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Gastroparesis Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Gastroparesis Drugs Sales by Type
8.3 Middle East & Africa Gastroparesis Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gastroparesis Drugs
10.3 Manufacturing Process Analysis of Gastroparesis Drugs
10.4 Industry Chain Structure of Gastroparesis Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gastroparesis Drugs Distributors
11.3 Gastroparesis Drugs Customer
12 World Forecast Review for Gastroparesis Drugs by Geographic Region
12.1 Global Gastroparesis Drugs Market Size Forecast by Region
12.1.1 Global Gastroparesis Drugs Forecast by Region (2023-2028)
12.1.2 Global Gastroparesis Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gastroparesis Drugs Forecast by Type
12.7 Global Gastroparesis Drugs Forecast by Application
13 Key Players Analysis
13.1 Sumitomo
13.1.1 Sumitomo Company Information
13.1.2 Sumitomo Gastroparesis Drugs Product Offered
13.1.3 Sumitomo Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sumitomo Main Business Overview
13.1.5 Sumitomo Latest Developments
13.2 Cadila Pharmaceuticals
13.2.1 Cadila Pharmaceuticals Company Information
13.2.2 Cadila Pharmaceuticals Gastroparesis Drugs Product Offered
13.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Cadila Pharmaceuticals Main Business Overview
13.2.5 Cadila Pharmaceuticals Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Gastroparesis Drugs Product Offered
13.3.3 Sanofi Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Teva
13.4.1 Teva Company Information
13.4.2 Teva Gastroparesis Drugs Product Offered
13.4.3 Teva Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Teva Main Business Overview
13.4.5 Teva Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Gastroparesis Drugs Product Offered
13.5.3 Johnson & Johnson Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Gastroparesis Drugs Product Offered
13.6.3 Pfizer Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Kyowa Kirin Pharmaceuticals
13.7.1 Kyowa Kirin Pharmaceuticals Company Information
13.7.2 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Offered
13.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Kyowa Kirin Pharmaceuticals Main Business Overview
13.7.5 Kyowa Kirin Pharmaceuticals Latest Developments
13.8 Hanmi Pharm
13.8.1 Hanmi Pharm Company Information
13.8.2 Hanmi Pharm Gastroparesis Drugs Product Offered
13.8.3 Hanmi Pharm Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hanmi Pharm Main Business Overview
13.8.5 Hanmi Pharm Latest Developments
13.9 Ani Pharmaceuticals
13.9.1 Ani Pharmaceuticals Company Information
13.9.2 Ani Pharmaceuticals Gastroparesis Drugs Product Offered
13.9.3 Ani Pharmaceuticals Gastroparesis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Ani Pharmaceuticals Main Business Overview
13.9.5 Ani Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Gastroparesis Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Gastroparesis Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Prokinetic Agents
Table 4. Major Players of Antiemetic Agents
Table 5. Major Players of Others
Table 6. Global Gastroparesis Drugs Sales by Type (2017-2022) & (Kg)
Table 7. Global Gastroparesis Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Gastroparesis Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Gastroparesis Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Gastroparesis Drugs Sale Price by Type (2017-2022) & (US$/mg)
Table 11. Global Gastroparesis Drugs Sales by Application (2017-2022) & (Kg)
Table 12. Global Gastroparesis Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Gastroparesis Drugs Revenue by Application (2017-2022)
Table 14. Global Gastroparesis Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Gastroparesis Drugs Sale Price by Application (2017-2022) & (US$/mg)
Table 16. Global Gastroparesis Drugs Sales by Company (2020-2022) & (Kg)
Table 17. Global Gastroparesis Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Gastroparesis Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Gastroparesis Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Gastroparesis Drugs Sale Price by Company (2020-2022) & (US$/mg)
Table 21. Key Manufacturers Gastroparesis Drugs Producing Area Distribution and Sales Area
Table 22. Players Gastroparesis Drugs Products Offered
Table 23. Gastroparesis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Gastroparesis Drugs Sales by Geographic Region (2017-2022) & (Kg)
Table 27. Global Gastroparesis Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Gastroparesis Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Gastroparesis Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Gastroparesis Drugs Sales by Country/Region (2017-2022) & (Kg)
Table 31. Global Gastroparesis Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Gastroparesis Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Gastroparesis Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Gastroparesis Drugs Sales by Country (2017-2022) & (Kg)
Table 35. Americas Gastroparesis Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Gastroparesis Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Gastroparesis Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Gastroparesis Drugs Sales by Type (2017-2022) & (Kg)
Table 39. Americas Gastroparesis Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Gastroparesis Drugs Sales by Application (2017-2022) & (Kg)
Table 41. Americas Gastroparesis Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Gastroparesis Drugs Sales by Region (2017-2022) & (Kg)
Table 43. APAC Gastroparesis Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Gastroparesis Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Gastroparesis Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Gastroparesis Drugs Sales by Type (2017-2022) & (Kg)
Table 47. APAC Gastroparesis Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Gastroparesis Drugs Sales by Application (2017-2022) & (Kg)
Table 49. APAC Gastroparesis Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Gastroparesis Drugs Sales by Country (2017-2022) & (Kg)
Table 51. Europe Gastroparesis Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Gastroparesis Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Gastroparesis Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Gastroparesis Drugs Sales by Type (2017-2022) & (Kg)
Table 55. Europe Gastroparesis Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Gastroparesis Drugs Sales by Application (2017-2022) & (Kg)
Table 57. Europe Gastroparesis Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Gastroparesis Drugs Sales by Country (2017-2022) & (Kg)
Table 59. Middle East & Africa Gastroparesis Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Gastroparesis Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Gastroparesis Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Gastroparesis Drugs Sales by Type (2017-2022) & (Kg)
Table 63. Middle East & Africa Gastroparesis Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Gastroparesis Drugs Sales by Application (2017-2022) & (Kg)
Table 65. Middle East & Africa Gastroparesis Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Gastroparesis Drugs
Table 67. Key Market Challenges & Risks of Gastroparesis Drugs
Table 68. Key Industry Trends of Gastroparesis Drugs
Table 69. Gastroparesis Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Gastroparesis Drugs Distributors List
Table 72. Gastroparesis Drugs Customer List
Table 73. Global Gastroparesis Drugs Sales Forecast by Region (2023-2028) & (Kg)
Table 74. Global Gastroparesis Drugs Sales Market Forecast by Region
Table 75. Global Gastroparesis Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Gastroparesis Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Gastroparesis Drugs Sales Forecast by Country (2023-2028) & (Kg)
Table 78. Americas Gastroparesis Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Gastroparesis Drugs Sales Forecast by Region (2023-2028) & (Kg)
Table 80. APAC Gastroparesis Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Gastroparesis Drugs Sales Forecast by Country (2023-2028) & (Kg)
Table 82. Europe Gastroparesis Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Gastroparesis Drugs Sales Forecast by Country (2023-2028) & (Kg)
Table 84. Middle East & Africa Gastroparesis Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Gastroparesis Drugs Sales Forecast by Type (2023-2028) & (Kg)
Table 86. Global Gastroparesis Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Gastroparesis Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Gastroparesis Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Gastroparesis Drugs Sales Forecast by Application (2023-2028) & (Kg)
Table 90. Global Gastroparesis Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Gastroparesis Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Gastroparesis Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Sumitomo Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Sumitomo Gastroparesis Drugs Product Offered
Table 95. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2022)
Table 96. Sumitomo Main Business
Table 97. Sumitomo Latest Developments
Table 98. Cadila Pharmaceuticals Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Cadila Pharmaceuticals Gastroparesis Drugs Product Offered
Table 100. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2022)
Table 101. Cadila Pharmaceuticals Main Business
Table 102. Cadila Pharmaceuticals Latest Developments
Table 103. Sanofi Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Sanofi Gastroparesis Drugs Product Offered
Table 105. Sanofi Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2022)
Table 106. Sanofi Main Business
Table 107. Sanofi Latest Developments
Table 108. Teva Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Teva Gastroparesis Drugs Product Offered
Table 110. Teva Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2022)
Table 111. Teva Main Business
Table 112. Teva Latest Developments
Table 113. Johnson & Johnson Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Johnson & Johnson Gastroparesis Drugs Product Offered
Table 115. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2022)
Table 116. Johnson & Johnson Main Business
Table 117. Johnson & Johnson Latest Developments
Table 118. Pfizer Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Pfizer Gastroparesis Drugs Product Offered
Table 120. Pfizer Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2022)
Table 121. Pfizer Main Business
Table 122. Pfizer Latest Developments
Table 123. Kyowa Kirin Pharmaceuticals Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Offered
Table 125. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2022)
Table 126. Kyowa Kirin Pharmaceuticals Main Business
Table 127. Kyowa Kirin Pharmaceuticals Latest Developments
Table 128. Hanmi Pharm Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Hanmi Pharm Gastroparesis Drugs Product Offered
Table 130. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2022)
Table 131. Hanmi Pharm Main Business
Table 132. Hanmi Pharm Latest Developments
Table 133. Ani Pharmaceuticals Basic Information, Gastroparesis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Ani Pharmaceuticals Gastroparesis Drugs Product Offered
Table 135. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2022)
Table 136. Ani Pharmaceuticals Main Business
Table 137. Ani Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Gastroparesis Drugs
Figure 2. Gastroparesis Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gastroparesis Drugs Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Gastroparesis Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Gastroparesis Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Prokinetic Agents
Figure 10. Product Picture of Antiemetic Agents
Figure 11. Product Picture of Others
Figure 12. Global Gastroparesis Drugs Sales Market Share by Type in 2021
Figure 13. Global Gastroparesis Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Gastroparesis Drugs Consumed in Diabetic Gastroparesis
Figure 15. Global Gastroparesis Drugs Market: Diabetic Gastroparesis (2017-2022) & (Kg)
Figure 16. Gastroparesis Drugs Consumed in Idiopathic Gastroparesis
Figure 17. Global Gastroparesis Drugs Market: Idiopathic Gastroparesis (2017-2022) & (Kg)
Figure 18. Global Gastroparesis Drugs Sales Market Share by Application (2017-2022)
Figure 19. Global Gastroparesis Drugs Revenue Market Share by Application in 2021
Figure 20. Gastroparesis Drugs Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Gastroparesis Drugs Revenue Market Share by Company in 2021
Figure 22. Global Gastroparesis Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Gastroparesis Drugs Revenue Market Share by Geographic Region in 2021
Figure 24. Global Gastroparesis Drugs Sales Market Share by Region (2017-2022)
Figure 25. Global Gastroparesis Drugs Revenue Market Share by Country/Region in 2021
Figure 26. Americas Gastroparesis Drugs Sales 2017-2022 (Kg)
Figure 27. Americas Gastroparesis Drugs Revenue 2017-2022 ($ Millions)
Figure 28. APAC Gastroparesis Drugs Sales 2017-2022 (Kg)
Figure 29. APAC Gastroparesis Drugs Revenue 2017-2022 ($ Millions)
Figure 30. Europe Gastroparesis Drugs Sales 2017-2022 (Kg)
Figure 31. Europe Gastroparesis Drugs Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Gastroparesis Drugs Sales 2017-2022 (Kg)
Figure 33. Middle East & Africa Gastroparesis Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Americas Gastroparesis Drugs Sales Market Share by Country in 2021
Figure 35. Americas Gastroparesis Drugs Revenue Market Share by Country in 2021
Figure 36. United States Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Gastroparesis Drugs Sales Market Share by Region in 2021
Figure 41. APAC Gastroparesis Drugs Revenue Market Share by Regions in 2021
Figure 42. China Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Gastroparesis Drugs Sales Market Share by Country in 2021
Figure 49. Europe Gastroparesis Drugs Revenue Market Share by Country in 2021
Figure 50. Germany Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Gastroparesis Drugs Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Gastroparesis Drugs Revenue Market Share by Country in 2021
Figure 57. Egypt Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Gastroparesis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Gastroparesis Drugs in 2021
Figure 63. Manufacturing Process Analysis of Gastroparesis Drugs
Figure 64. Industry Chain Structure of Gastroparesis Drugs
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
